LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,891 | -16.9% | 115,000 | 0.0% | 2.63% | -20.3% |
| Q2 2023 | $8,292 | -2.0% | 115,000 | 0.0% | 3.30% | -0.7% |
| Q1 2023 | $8,459 | +10.1% | 115,000 | 0.0% | 3.32% | +14.5% |
| Q4 2022 | $7,682 | -99.9% | 115,000 | 0.0% | 2.90% | -30.4% |
| Q3 2022 | $9,902,000 | -3.5% | 115,000 | 0.0% | 4.17% | -3.3% |
| Q2 2022 | $10,261,000 | -20.7% | 115,000 | 0.0% | 4.31% | +4.6% |
| Q1 2022 | $12,937,000 | +11.7% | 115,000 | +53.3% | 4.12% | +4.8% |
| Q4 2021 | $11,585,000 | – | 75,000 | – | 3.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |